Cardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen

Similar documents
Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients

JOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY

Prof. Andrzej Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia Katowice, Poland.

Prevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

CKD and CVD. Jamal Salameh, MD, FACP, FASN First Coast Nephrology

β adrenergic blockade, a renal perspective Prof S O McLigeyo

Doppler ultrasound, see Ultrasonography. Magnetic resonance imaging (MRI), kidney oxygenation assessment 75

Structural abnormalities of the heart and vascular system in CKD & Dialysis - Thick but weak

The Role of Vitamin D in Heart Disease. Janet Long, MSN, ACNP, CLS, FAHA, FNLA Cardiovascular Institute Rhode Island Hospital and The Miriam Hospital

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Cardiorenal and Renocardiac Syndrome

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Inflammation in Renal Disease

Metabolic Syndrome and Chronic Kidney Disease

Left ventricular hypertrophy: why does it happen?

Obesity mediated hypertension and renal dysfunction

The Triple Threat. Cardiac Care in the NT Annual Workshop 2017 is proudly supported by:

Professor Suetonia Palmer

Arteriosclerosis & Atherosclerosis

The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought.

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with

Dr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey.

Morbidity & Mortality from Chronic Kidney Disease

Diabetic Kidney Disease: Update. GKA Master Class. Istanbul 2011

The hypertensive kidney and its Management

FOCUS ON CARDIOVASCULAR DISEASE

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

The Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction

Nephrology Unit- CHU Liège- Ulg- Belgium

Chronic kidney disease

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.

THE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Cardiovascular System and Health. Chapter 15

DIABETES AND YOUR KIDNEYS

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Cardiovascular Protection and the RAS

PATIENTS AND METHODS:

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

SLOWING PROGRESSION OF KIDNEY DISEASE. Mark Rosenberg MD University of Minnesota

Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018

HTA ET DIALYSE DR ALAIN GUERIN

Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano

Update in Hypertension

Cardiorenal Syndrome

TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009

Report and Opinion 2016;8(12)

AGING KIDNEY IN HIV DISEASE

Structure and organization of blood vessels

Stefanos K. Roumeliotis. Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece. Stefanos K.

ADVANCES IN MANAGEMENT OF HYPERTENSION

Stages of Chronic Kidney Disease (CKD)

LXIV: DRUGS: 4. RAS BLOCKADE

David Ramenofsky, MD Bryan Kestenbaum, MD

ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world

Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time. Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France

Protecting the heart and kidney: implications from the SHARP trial

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

An Epidemiological Overview

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012

Cardiovascular Diseases in CKD

( 1) Framingham Heart

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

10/17/16. Assessing cardiovascular risk through use of inflammation testing

Diabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2

Clinical application of Arterial stiffness. pulse wave analysis pulse wave velocity

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

Chronic Kidney Disease. Paul Cockwell Queen Elizabeth Hospital Birmingham

Managing Chronic Kidney Disease: Reducing Risk for CKD Progression

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

Secondary Hyperparathyroidism: Where are we now?

What should you do next? Presenter Disclosure Information. Learning Objectives. Case: George

Correlation of novel cardiac marker

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

When should you treat blood pressure in the young?

The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century?

Concept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA

VALUE OF ACEI IN THE MANAGEMENT OF HYPERTENSION

The Study of Endothelial Function in CKD and ESRD

Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009

ARGININE VASOPRESSIN (AVP)

Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman

Chronic Kidney Disease - An Overview

Predicting and changing the future for people with CKD

Pathology of Coronary Artery Disease

Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease

Individual Study Table Referring to Part of Dossier: Volume: Page:

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept

2/11/2017. Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox. Disclosures. Carl J. Lavie, MD, FACC, FACP, FCCP

Figure 1 LVH: Allowed Cost by Claim Volume (Data generated from a Populytics analysis).

CAD in Chronic Kidney Disease. Kuang-Te Wang

Blood Vessels. Dr. Nabila Hamdi MD, PhD

Transcription:

Cardiovascular Complications Of Chronic Kidney Disease Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen

Markers of kidney dysfunction Raised Albumin / Creatinine ratio Proteinuria. Abnormalities in urine sediments (RBC casts). Abnormal findings on imaging (U/S scan etc.). GFR overall best measure of kidney damage. Kidney dysfunction can be diagnosed without knowledge of the cause

Stages of CKD STAGE GFR Action 1 90 ( GFR) Dx. + Rx. of comorb slow progression CVD risk reduction 2 60 89 Estimating progression 3 30 59 Evaluate & Rx. Compli. 4 15 29 Prepare for kid. Replac 5 < 15 (or dialysis) Kidney replacement

CVD in CKD: Epidemiology 1 40 50% of all deaths in CKD are due to CVD. Deaths from CVD are 20 times more in CKD than general population. Increase in prevalence of M.I. Increase in rate of fatal M.I.

CVD in CKD: Epidemiology 2 Some facts: 75% patients on Dialysis have evidence of Left ventricular hypertrophy. 30% patients before reaching ESRD will have IHD. Patients with decreased GFR are more likely to die of CVD than ESRD.

Atherosclerosis (AS) and CKD Some facts AS is accelerated in CKD AS is more frequent in CKD AS is more prevalent in CKD Atheroma size is bigger Vessel wall is thickened in CKD

Atherosclerosis and CKD 2 Some facts Morphology of coronary plaque is different in uremic and non-uremic patients. Stay s plaque classification I VII Uremic patients usually have type VII plaques (i.e. with calcification & AS). AS is more advanced in CKD.

Risk factors for CVD in CKD Hypertension Diabetes Hyperlipidemia Smoking

Uremia specific CVD risk factors Anemia Hyperphosphatemia. Chronic inflammation. Oxidative stress. Albuminuria. Thrombogenic risk factors.

Uremia specific CVD risk factors Anemia Hyperphosphatemia. Chronic inflammation. Oxidative stress. Albuminuria. Thrombogenic risk factors.

Chronic inflammation in CKD 1 CRP is produced from hepatocytes in response to cytokines IL-1 & IL-6. CRP is raised in CKD. Raised CRP has been found to be predictor of all cause and CVD mortality in CKD. It is not clear if CRP is raised due to Chronic Inflammation or it is a cause of AS and endothelial dysfunction.

Chronic inflammation in CKD 2 IL-6 is produced by T Lymph., monocytes, dendritic cells, adipocytes & fibroblasts. It is a pro-inflmmatory cytokine. IL-6 production is induced by TNF-α, IL1-β, bacterial LPS & oxidative stress. Raised IL-6 levels have been have been seen in CKD. Raised IL-6 in dialysis patients predicts AS, CV and all cause mortality.

Chronic inflammation in CKD 3 TNF-α, another pro-inflammatory cytokine. It affects lipid metabolism, endothelial dysfunction, insulin secretion, activation of immune cells. CKD is associated with raised TNF-α. Creates insulin insensitivity. Up regulates renin-angiotensin system.

Uremia specific CVD risk factors Anemia Hyperphosphatemia. Chronic inflammation. Oxidative stress. Albuminuria. Thrombogenic risk factors.

Oxidative stress and CKD Accumulation of highly reactive oxygen radicals. Oxygen superoxide, Hydro-oxyradicals, hydroxyperoxide. These radicals not necessarily pathogenic per se.. but these act as physiologic signal molecules for Angiotensin II, which is proinflammatory.

CKD and Heart LV measurement (LVH/LVF) is an early abnormality. It affects 39 74% pre-dialysis patients...and 82% on maintenance dialysis. LVH predicts mortality in CKD. LV systolic & diastolic dysfunction contributes to mortality in CKD.

Predictors of LVH in CKD Anemia. Raised PTH. Increased sympathetic tone. Hypertension.

CVD risks in CKD INDEPENDENT OF A.S. Anemia and CVD in CKD Decreased Hb results in decreased Oxygen delivery & increased sympathetic activity. Increased heart rate. Increased cardiac output leading to LVF. Controversy: correction of anemia does not result in decrease in CVD events.

CVD risks in CKD INDEPENDENT OF A.S. CKD patients show increased sympathetic tone. During dialysis, catecholamines levels comparable to phaeochromocytoma have been found. 2ndry hyperparathyroidism, driven by Ca and Po4 abnormalities contributes to CVD risk.

Conclusion Deaths from CVD in CKD are 20-times high. In CKD the CVD occurs very early. A.S. is the main underlying problem. CKD is a pro-inflammatory state leading to AS. CVD risk factors are common in CKD. CKD specific CVD risk factors complicate the problems further in CKD. CVD events in CKD are more prevalent, more frequent and more fatal. Early detection, treatment of risk factors and delay the progression of CKD is needed.

Conclusion 2 Systolic and diastolic dysnfunction is common and contributes to CVD mortality. Increased prevalence of LVH. Increased prevalence of PVD Increased prevalence of CVA

Thank You